The effect of primaquine on gametocyte development and clearance in the treatment of uncomplicated falciparum malaria with dihydroartemisinin- piperaquine in South Sumatra, Western Indonesia: An open-label, randomized, controlled trial

Clinical Infectious Diseases

Volumn 56, Issue 5, 2013, Pages 685-693

  Sutanto, Inge ^a   Suprijanto, Sri ^b   Kosasih, Ayleen ^a   Dahlan, Muhamad S ^c   Syafruddin, Din ^d   Kusriastuti, Rita ^b   Hawley, William A ^e   Lobo, Neil F ^f   Ter Kuile, Feiko O ^g  

^a UNIVERSITY OF INDONESIA   (Indonesia)

^b MINISTRY OF HEALTH   (Indonesia)

^c Indonesia Power CoLtd   (Indonesia)

^d EIJKMAN INSTITUTE FOR MOLECULAR BIOLOGY   (Indonesia)

^e UNITED NATIONS CHILDREN'S FUND   (Indonesia)

^f UNIVERSITY OF NOTRE DAME   (United States)

^g LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

dihydroartemisinin piperaquine; gametocyte P. falciparum; Indonesia; primaquine

Indexed keywords

D ARTEPP; DIHYDROARTEMISININ PLUS PIPERAQUINE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HEMOGLOBIN; PRIMAQUINE; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADD ON THERAPY; ADOLESCENT; ADULT; ANTIMALARIAL ACTIVITY; ANTIMICROBIAL THERAPY; ARTICLE; CELL DENSITY; CELL MATURATION; CHILD; CHILDHOOD DISEASE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DIARRHEA; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; DRUG WITHDRAWAL; ENZYME BLOOD LEVEL; FATIGUE; FEMALE; GAMETOCYTE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; INDONESIA; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MICROSCOPY; MONOTHERAPY; NAUSEA; OPEN STUDY; PARASITE SURVIVAL; PARESTHESIA; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SINGLE DRUG DOSE; VOMITING;

ADOLESCENT; ADULT; ANTIMALARIALS; ARTEMISININS; CHILD; DRUG THERAPY, COMBINATION; FEMALE; GLUCOSEPHOSPHATE DEHYDROGENASE; HUMANS; INDONESIA; MALARIA, FALCIPARUM; MALE; PARASITEMIA; PLASMODIUM FALCIPARUM; QUINOLINES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84873633438     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis959     Document Type: Article

References (29)

1. World Health Organization. Case management in the context of malaria elimination: use of gametocytocidal drugs to reduce transmission. In: Guidelines for the treatment of malaria, World Health Organization, ed. 2nd ed. Geneva, Switzerland: WHO Press, 2010:58.
2. White NJ. The role of anti-malarial drugs in eliminating malaria. Malar J 2008; 7(Suppl 1):S8.
3. Lederman ER, Maguire JD, Sumawinata IW, et al. Combined chloroquine, sulfadoxine/pyrimethamine and primaquine against Plasmodium falciparum in Central Java, Indonesia. Malar J 2006; 5:108.
4. ter Kuile F, White NJ, Holloway P, Pasvol G, Krishna S. Plasmodium falciparum: in vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria. Exp Parasitol 1993; 76:85-95.
5. Skinner TS, Manning LS, Johnston WA, Davis TM. In vitro stagespecific sensitivity of Plasmodium falciparum to quinine and artemisinin drugs. Int J Parasitol 1996; 26:519-25.
6. Kumar N, Zheng H. Stage-specific gametocytocidal effect in vitro of the antimalaria drug qinghaosu on Plasmodium falciparum. Parasitol Res 1990; 76:214-8.
7. Mehra N, Bhasin VK. In vitro gametocytocidal activity of artemisinin and its derivatives on Plasmodium falciparum. Jpn J Med Sci Biol 1993; 46:37-43.
8. Hawking F, Wilson ME, Gammage K. Evidence for cyclic development and short-lived maturity in the gametocytes of Plasmodium falciparum. Trans R Soc Trop Med Hyg 1971; 65:549-59.
9. Price RN, Nosten F, Luxemburger C, et al. Effects of artemisinin derivatives on malaria transmissibility. Lancet 1996; 347:1654-8.
10. Targett G, Drakeley C, Jawara M, et al. Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. J Infect Dis 2001; 183:1254-9.
11. Sutherland CJ, Ord R, Dunyo S, et al. Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of coartemether. PLoS Med 2005; 2:e92.
12. Pukrittayakamee S, Chotivanich K, Chantra A, Clemens R, Looareesuwan S, White NJ. Activities of artesunate and primaquine against asexual-and sexual-stage parasites in falciparum malaria. Antimicrob Agents Chemother 2004; 48:1329-34.
13. Drakeley CJ, Jawara M, Targett GA, et al. Addition of artesunate to chloroquine for treatment of Plasmodium falciparum malaria in Gambian children causes a significant but short-lived reduction in infectiousness for mosquitoes. Trop Med Int Health 2004; 9:53-61.
14. Bousema JT, Schneider P, Gouagna LC, et al. Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum. J Infect Dis 2006; 193:1151-9.
15. Tangpukdee N, Krudsood S, Srivilairit S, et al. Gametocyte clearance in uncomplicated and severe Plasmodium falciparum malaria after artesunate-mefloquine treatment in Thailand. Korean J Parasitol 2008; 46:65-70.
16. Zwang J, Ashley EA, Karema C, et al. Safety and efficacy of dihydroartemisinin-piperaquine in falciparum malaria: a prospective multicentre individual patient data analysis. PLoS One 2009; 4:e6358.
17. Kirnowardoyo S. Status of Anopheles malaria vectors in Indonesia. Southeast Asian J Trop Med Public Health 1985; 16:129-32.
18. Sutanto I, Endawati D, Ling LH, Laihad F, Setiabudy R, Baird JK. Evaluation of chloroquine therapy for vivax and falciparum malaria in southern Sumatra, western Indonesia. Malar J 2010; 9:52.
19. Lawpoolsri S, Klein EY, Singhasivanon P, et al. Optimally timing primaquine treatment to reduce Plasmodium falciparum transmission in low endemicity Thai-Myanmar border populations. Malar J 2009; 8:159.
20. Wooden J, Kyes S, Sibley CH. PCR and strain identification in Plasmodium falciparum. Parasitol Today 1993; 9:303-5.
21. World Health Organization. Methods and techniques for clinical trials on antimalarial drug efficacy: Genotyping to identify parasite populations. In: Informal consultation organized by the Medicines for Malaria Venture and cosponsored by the World Health Organization, 29-31 May 2007, Amsterdam, the Netherlands. Geneva, Switzerland: WHO, 2008.
22. WorldWide Antimalarial Resistance Network (WWARN). Clinical module. Data management and statistical analysis plan. Available at: http://www.wwarn.org/ about-us/scientific-groups/clinical. Accessed 4 December 2012.
23. Smithuis F, Kyaw MK, Phe O, et al. Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial. Lancet Infect Dis 2010; 10:673-81.
24. Shekalaghe S, Drakeley C, Gosling R, et al. Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate. PLoS One, 2007; 2:e1023.
25. Price AH, Fletcher KA. Ethnic differences in the reactions to drugs and xenobiotics. The metabolism and toxicity of primaquine. Prog Clin Biol Res, 1986; 214:261-78.
26. Shekalaghe SA, ter Braak R, Daou M, et al. In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals. Antimicrob Agents Chemother 2010; 54:1762-8.
27. Piyaphanee W, Krudsood S, Tangpukdee N, et al. Emergence and clearance of gametocytes in uncomplicated Plasmodium falciparum malaria. Am J Trop Med Hyg 2006; 74:432-5.
28. El-Sayed B, El-Zaki SE, Babiker H, et al. A randomized open-label trial of artesunate-sulfadoxine-pyrimethamine with or without primaquine for elimination of sub-microscopic P. falciparum parasitaemia and gametocyte carriage in eastern Sudan. PLoS One, 2007; 2:e1311.
29. World Health Organization. Single dose primaquine as a gametocytide in Plasmodium falciparum malaria. Updated WHO Policy Recommendation (October 2012). Available at: http://www.who.int/malaria/mpac/policyrecommendations/en/index. html. Accessed 4 December 2012.